Publication Type : Patents
Publisher : Number 201641018401, India .
Source : Number 201641018401, India (2016)
Campus : Kochi
School : School of Pharmacy
Department : Pharmacognosy
Year : 2016
Abstract : The present invention includes Uttroside B compositions and method for the treatment of hepatocellular carcinoma. Chemotherapeutic options for liver cancer are limited and the prognosis of HCC patients remains dismal. Sorafenib, is the only drug currently available for the treatment of hepatocellular carcinoma.
Cite this Research Publication : Lekshmi R Nath and Anto, R. John, “Uttroside B and Derivatives Thereof as Therapeutics for Hepatocellular Carcinoma”, U.S. Patent 2016410184012016.